STOCK TITAN

Laser Photonics Announces Exercise of Warrants for $2.5 Million Gross Proceeds

(Neutral)
Tags

Laser Photonics (NASDAQ:LASE) entered into definitive agreements for the immediate cash exercise of outstanding warrants to purchase up to 2,528,572 shares of common stock at $0.975 per share, originally issued in April 2026. According to Laser Photonics, this is expected to generate approximately $2.5 million in gross proceeds before placement agent fees and offering expenses, with H.C. Wainwright & Co. acting as exclusive placement agent.

In return, the company will issue new unregistered Series A-7 warrants for up to 800,000 shares and Series A-8 warrants for up to 4,257,144 shares, each with a $0.975 exercise price and immediate exercisability. The offering is expected to close on or about July 20, 2026, with net proceeds intended for working capital and general corporate purposes.

Loading...
Loading translation...

Positive

  • Approx. $2.5 million gross proceeds from warrant exercise at $0.975 per share
  • Immediate cash exercise of up to 2,528,572 existing warrants
  • New warrants provide potential future capital via up to 5,057,144 additional shares
  • Net proceeds earmarked for working capital and general corporate purposes

Negative

  • New Series A-7 and A-8 warrants for up to 5,057,144 shares add potential dilution
  • Gross proceeds of $2.5 million will be reduced by placement agent fees and expenses
  • Resale of shares from new warrants depends on effectiveness of a future SEC registration statement

News Explained

The agreement adds potential dilution mechanics now, but its cash proceeds remain conditional until the 2026-07-20 closing.

The 2026-07-17 release describes definitive agreements, not a completed financing: closing is expected on or about 2026-07-20 subject to customary conditions, and completion would add common shares plus immediately exercisable warrants that can reduce existing holders’ percentage ownership.

The shares issuable on exercise of the existing warrants are registered under an effective Form S-1, whereas the new Series A-7 and A-8 warrants and their underlying shares are unregistered; the company agreed to file a resale registration statement for those shares.

A private placement sells securities to selected investors outside a public offering, and an S-1 registers securities for sale but does not itself sell them. The resale filing therefore addresses the registration status of the new warrant shares, not their exercise or issuance.

Using the 2026-03-31 first-quarter report’s operating cash outflow, the release’s approximately $2.5 million gross proceeds equals 122.1 days of that reported cash use; first-quarter cash and equivalents of $1,627,600 equals 79.5 days on the same basis.

The first state checkpoint is the 2026-07-20 closing; thereafter, the material ownership line item is exercise of the A-7 and A-8 warrants, because resulting shares would further increase total shares and dilute existing ownership.

Sources and calculations
  • Offering gross vs quarterly operating cash outflow, in days of cash use $2,500,000 / ($1,842,774 / 90) = [object Object]
  • Cash and equivalents vs quarterly operating cash outflow, in days of cash use $1,627,600 / ($1,842,774 / 90) = [object Object]

Market reaction: LASE -20.22% on warrant exercise financing

-20.22% 4.3x vol
37 alerts
-20.22% News Effect
-26.6% Trough in 12 min
-$15M Valuation Impact
$58.61M Market Cap
4.3x Rel. Volume

On the day this news was published, LASE declined 20.22%, reflecting a significant negative market reaction. Argus tracked a trough of -26.6% from its starting point during tracking. Our momentum scanner triggered 37 alerts that day, indicating elevated trading interest and price volatility. This price movement removed approximately $15M from the company's valuation, bringing the market cap to $58.61M at that time. Trading volume was very high at 4.3x the daily average, suggesting heavy selling pressure.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock dropped -20.2% in the session following this news. A sharp decline would be consistent wit...
Analysis

The stock dropped -20.2% in the session following this news. A sharp decline would be consistent with the stock’s history around offerings, where similar financings averaged a -17.37% move after announcement. Added Series A-7 and A-8 warrants expand potential dilution, and recent insider activity has skewed toward net selling, reinforcing pressure.

Key Figures

Shares under exercised warrants: 2,528,572 shares Exercise price (existing warrants): $0.975 per share Gross proceeds: $2.5 million +5 more
8 metrics
Shares under exercised warrants 2,528,572 shares Immediate exercise of April 2026 warrants
Exercise price (existing warrants) $0.975 per share April 2026 warrants being exercised
Gross proceeds $2.5 million Expected from warrant exercises before fees and expenses
Series A-7 warrant shares 800,000 shares New unregistered Series A-7 warrants issued as inducement
Series A-8 warrant shares 4,257,144 shares New unregistered Series A-8 warrants issued as inducement
Exercise price (new warrants) $0.975 per share New Series A-7 and A-8 warrants
Series A-7 term five years From effective date of Resale Registration Statement
Series A-8 term twenty-four months From effective date of Resale Registration Statement

Previous Offering Reports

5 past events · Latest: Apr 29 (Negative)
Same Type Pattern 5 events
Date Event Sentiment 24h Move Catalyst
Apr 29 warrant exercise closing Negative -4.3% Closed cash exercise of warrants raising $4.0M gross with new warrants.
Apr 27 warrant exercise deal Negative -19.4% Announced immediate exercise of warrants for $4.0M gross and new warrants.
Mar 17 warrant exercise closing Negative -6.8% Closed reduced‑price warrant exercises raising $1.5M and issued new warrants.
Mar 16 warrant exercise deal Negative -18.0% Announced immediate exercise of warrants for $1.5M gross and new warrants.
Feb 06 public equity offering Negative -38.4% Priced $5.0M public offering with common shares and Series A‑1/A‑2 warrants.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Past financing and warrant‑related offerings for this company have typically been followed by share price declines.

Key Terms

form s-1, placement agent, resale registration statement
3 terms
form s-1 regulatory
"registered pursuant to an effective registration statement on Form S-1 (No. 333-297400)"
A Form S-1 is the registration filing a company submits to the U.S. Securities and Exchange Commission when it plans to offer stock to the public, most commonly for an initial public offering. Think of it as the company’s full disclosure packet or blueprint: it contains audited financials, business description, management background, risk factors and details of the offering, giving investors the information needed to judge the company’s financial health and potential risks before buying shares.
placement agent financial
"H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering."
A placement agent is a professional or firm that helps organizations raise money from investors, such as individuals, institutions, or funds. They act like matchmakers, connecting those seeking investments with the right investors and guiding the process to ensure successful funding. For investors, they can provide access to exclusive opportunities and help navigate complex fundraising efforts.
resale registration statement regulatory
"file a registration statement with the SEC covering the resale of the shares"
A resale registration statement is a document filed with regulators that allows existing shareholders to sell their shares to the public. It provides the necessary legal approval and information for these shares to be resold on the market, helping to increase the availability of shares for trading. For investors, it signals that shares held by current owners can be offered for sale, potentially affecting share prices and market liquidity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

ORLANDO, FL / ACCESS Newswire / July 17, 2026 / Laser Photonics Corporation (NASDAQ:LASE) (the "Company"), a global leader in laser systems for industrial and defense applications, today announced the entry into definitive agreements for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 2,528,572 shares of common stock of the Company originally issued in April 2026, having an exercise price of $0.975 per share. The shares of common stock issuable upon exercise of the warrants are registered pursuant to an effective registration statement on Form S-1 (No. 333-297400). The gross proceeds to the Company from the exercise of the warrants are expected to be approximately $2.5 million, prior to deducting placement agent fees and estimated offering expenses.

H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.

In consideration for the immediate exercise of the warrants for cash, the Company will issue new unregistered Series A-7 warrants to purchase up to 800,000 shares of common stock and new unregistered Series A-8 warrants to purchase up to 4,257,144 shares of common stock. The new warrants will have an exercise price of $0.975 per share and will be exercisable immediately upon issuance. The Series A-7 new warrants will expire five years after the effective date of the Resale Registration Statement (as defined below) and the Series A-8 new warrants will expire twenty-four months after the effective date of the Resale Registration Statement.

The offering is expected to close on or about July 20, 2026, subject to satisfaction of customary closing conditions. The Company intends to use the net proceeds from the offering for working capital and general corporate purposes.

The new warrants described above were offered in a private placement pursuant to an applicable exemption from the registration requirements of the Securities Act of 1933, as amended (the "1933 Act") and, along with the shares of common stock issuable upon their exercise, have not been registered under the 1933 Act, and may not be offered or sold in the United States absent registration with the Securities and Exchange Commission ("SEC") or an applicable exemption from such registration requirements. The Company has agreed to file a registration statement with the SEC covering the resale of the shares of common stock issuable upon exercise of the new warrants (the "Resale Registration Statement").

This press release shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.

About Laser Photonics Corporation

Laser Photonics Corporation (NASDAQ:LASE) is a global leader in laser systems for industrial and defense applications. The Company develops and manufactures advanced laser technologies used in cleaning, surface preparation, and precision material processing across demanding operating environments. Laser Photonics serves a broad range of end markets, including defense and government, aerospace, energy, maritime, automotive, and advanced manufacturing. Through a combination of internal development, strategic acquisitions, and partnerships, the Company continues to expand its product portfolio and address new applications where performance, efficiency, and environmental considerations are critical. For more information, please visit https://laserphotonics.com.

Cautionary Note Concerning Forward-Looking Statements

This press release contains forward-looking statements within the meaning of applicable securities laws, including statements regarding the completion of the offering, the satisfaction of customary closing conditions related to the offering and the intended use of net proceeds from the offering. These statements are based on current expectations as of the date of this press release and involve a number of risks and uncertainties, which may cause results and uses of proceeds to differ materially from those indicated by these forward-looking statements. These risks include, without limitation, those described under the caption "Risk Factors" in our Form 10-K for the fiscal year ended December 31, 2025. Any reader of this press release is cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this press release except as required by applicable laws or regulations.

Investor Relations Contact:
Lucas A. Zimmerman & Ian Scargill
MZ Group - MZ North America
(262) 357-2918
LASE@mzgroup.us
www.mzgroup.us

SOURCE: Laser Photonics Corp.



View the original press release on ACCESS Newswire

FAQ

What did Laser Photonics (NASDAQ:LASE) announce about warrant exercises on July 17, 2026?

Laser Photonics announced definitive agreements for the immediate cash exercise of certain outstanding warrants, expecting about $2.5 million in gross proceeds. According to Laser Photonics, these warrants cover up to 2,528,572 shares of common stock at an exercise price of $0.975 per share.

How much capital will Laser Photonics (LASE) raise from the July 2026 warrant exercise?

Laser Photonics expects approximately $2.5 million in gross proceeds from the immediate exercise of existing warrants. According to Laser Photonics, this figure is before deducting placement agent fees and estimated offering expenses, so net proceeds will be lower than the stated gross amount.

What are the terms of the new Series A-7 and A-8 warrants issued by Laser Photonics (LASE)?

Laser Photonics will issue new unregistered Series A-7 warrants for up to 800,000 shares and Series A-8 warrants for up to 4,257,144 shares. According to Laser Photonics, both series have a $0.975 exercise price, are exercisable immediately, and have different expiration periods.

When is the Laser Photonics (LASE) warrant exercise transaction expected to close?

The warrant exercise transaction is expected to close on or about July 20, 2026. According to Laser Photonics, closing is subject to the satisfaction of customary closing conditions typically associated with similar capital markets transactions and private placement warrant structures.

How will Laser Photonics (LASE) use the net proceeds from the July 2026 warrant exercise?

Laser Photonics intends to use the net proceeds for working capital and general corporate purposes. According to Laser Photonics, the final amount available will be after deducting placement agent fees and estimated offering expenses from the approximately $2.5 million gross proceeds.

Are the new Laser Photonics (LASE) Series A-7 and A-8 warrants registered with the SEC?

The new Series A-7 and A-8 warrants and their underlying shares are not initially registered under the 1933 Act. According to Laser Photonics, they were issued via private placement, and the company has agreed to file a Resale Registration Statement with the SEC.

What is the potential dilution from new Laser Photonics (LASE) warrants issued in July 2026?

Laser Photonics will issue new warrants exercisable for up to 5,057,144 shares of common stock. According to Laser Photonics, these include 800,000 Series A-7 and 4,257,144 Series A-8 warrants, all at a $0.975 exercise price and immediately exercisable upon issuance.